PL1784169T3 - Polimerowa matryca adhezyjna z grupami karboksylowymi przekształconymi w sole do przezskórnego stosowania - Google Patents
Polimerowa matryca adhezyjna z grupami karboksylowymi przekształconymi w sole do przezskórnego stosowaniaInfo
- Publication number
- PL1784169T3 PL1784169T3 PL05763405T PL05763405T PL1784169T3 PL 1784169 T3 PL1784169 T3 PL 1784169T3 PL 05763405 T PL05763405 T PL 05763405T PL 05763405 T PL05763405 T PL 05763405T PL 1784169 T3 PL1784169 T3 PL 1784169T3
- Authority
- PL
- Poland
- Prior art keywords
- carboxylic groups
- adhesive matrix
- transdermal use
- polymeric adhesive
- salified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001628A ITMI20041628A1 (it) | 2004-08-06 | 2004-08-06 | Sistema terapeutico a rilascio controllato per uso topico transdermico |
| EP05763405A EP1784169B1 (en) | 2004-08-06 | 2005-07-06 | Polymeric adhesive matrix with salified carboxylic groups for transdermal use |
| PCT/EP2005/007293 WO2006012966A1 (en) | 2004-08-06 | 2005-07-06 | Polymeric adhesive matrix with salified carboxylic groups for transdermal use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1784169T3 true PL1784169T3 (pl) | 2012-08-31 |
Family
ID=35149597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05763405T PL1784169T3 (pl) | 2004-08-06 | 2005-07-06 | Polimerowa matryca adhezyjna z grupami karboksylowymi przekształconymi w sole do przezskórnego stosowania |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US20080292708A1 (pl) |
| EP (1) | EP1784169B1 (pl) |
| JP (1) | JP2008509096A (pl) |
| CN (1) | CN101001616B (pl) |
| AT (1) | ATE550040T1 (pl) |
| AU (1) | AU2005268981B2 (pl) |
| CA (1) | CA2576087A1 (pl) |
| ES (1) | ES2387200T3 (pl) |
| IT (1) | ITMI20041628A1 (pl) |
| MX (1) | MX2007001560A (pl) |
| PL (1) | PL1784169T3 (pl) |
| PT (1) | PT1784169E (pl) |
| RU (1) | RU2401126C2 (pl) |
| WO (1) | WO2006012966A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7511121B2 (en) | 2001-03-09 | 2009-03-31 | Arnason Barry G W | Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| AU2011248904B2 (en) * | 2010-04-30 | 2014-02-27 | Teikoku Seiyaku Co., Ltd. | Propynylaminoindan transdermal compositions |
| JP5906302B2 (ja) | 2011-03-24 | 2016-04-20 | テイコク ファーマ ユーエスエー インコーポレーテッド | 作用剤層および作用剤変換層を含む経皮組成物 |
| US9913812B2 (en) | 2011-11-09 | 2018-03-13 | Teikoku Pharma Usa, Inc. | Methods for the treatment of skin neoplasms |
| DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| KR101856515B1 (ko) | 2012-11-02 | 2018-05-10 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 프로피닐아미노인단 경피 조성물 |
| EP3206673A1 (en) | 2014-10-17 | 2017-08-23 | Fidia Farmaceutici S.p.A. | Dermal therapeutic system with high adhesivity |
| PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
| CA3047354A1 (en) | 2016-12-20 | 2018-06-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| CA3067938A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
| CA3101420A1 (en) | 2018-06-20 | 2019-12-26 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| KR102068595B1 (ko) * | 2018-08-06 | 2020-01-21 | 고세윤 | 생체의료용 고분자를 포함하는 체온 감응형 점착제 조성물 및 이를 이용한 점착시트 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58103317A (ja) | 1981-12-12 | 1983-06-20 | Nitto Electric Ind Co Ltd | ヒドロゾル製剤 |
| CH643138A5 (de) * | 1983-08-29 | 1984-05-30 | Mepha Ag | Indomethacin enthaltende, gelartige salbe. |
| JPS6229516A (ja) * | 1985-07-30 | 1987-02-07 | Nitto Electric Ind Co Ltd | 医薬製剤 |
| DE3901551A1 (de) * | 1989-01-20 | 1990-07-26 | Lohmann Therapie Syst Lts | Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil |
| DE3913734C2 (de) * | 1989-04-26 | 1998-08-20 | Roehm Gmbh | Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht |
| US5041287A (en) * | 1989-05-22 | 1991-08-20 | Terry L. Driggers | Sprayable composition using acetone solvent |
| FR2709770B1 (fr) | 1993-09-10 | 1995-10-13 | Peller Entr | Mur de soutènement ou anti-bruit. |
| FR2719770A1 (fr) * | 1994-05-11 | 1995-11-17 | Lhd Lab Hygiene Dietetique | Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation. |
| DE4429791C2 (de) | 1994-08-23 | 1997-04-24 | Lohmann Therapie Syst Lts | Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung |
| ES2237415T5 (es) * | 1999-01-14 | 2008-12-16 | Noven Pharmaceuticals, Inc. | Composiciones dermicas. |
| DE19918106A1 (de) * | 1999-04-22 | 2000-10-26 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern |
| US6562369B2 (en) * | 1999-12-16 | 2003-05-13 | Dermatrends, Inc. | Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers |
| US6645520B2 (en) * | 1999-12-16 | 2003-11-11 | Dermatrends, Inc. | Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers |
| DE10035891A1 (de) * | 2000-07-24 | 2002-02-14 | Lohmann Therapie Syst Lts | Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen |
| DE10110391A1 (de) | 2001-03-03 | 2002-09-26 | Lohmann Therapie Syst Lts | Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff |
| ITMI20020798A1 (it) * | 2002-04-15 | 2003-10-15 | F T Holding S A | Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici |
-
2004
- 2004-08-06 IT IT001628A patent/ITMI20041628A1/it unknown
-
2005
- 2005-07-06 EP EP05763405A patent/EP1784169B1/en active Active
- 2005-07-06 CN CN2005800265976A patent/CN101001616B/zh active Active
- 2005-07-06 RU RU2007104354/04A patent/RU2401126C2/ru not_active IP Right Cessation
- 2005-07-06 PT PT05763405T patent/PT1784169E/pt unknown
- 2005-07-06 JP JP2007524204A patent/JP2008509096A/ja active Pending
- 2005-07-06 PL PL05763405T patent/PL1784169T3/pl unknown
- 2005-07-06 AT AT05763405T patent/ATE550040T1/de active
- 2005-07-06 CA CA002576087A patent/CA2576087A1/en not_active Abandoned
- 2005-07-06 WO PCT/EP2005/007293 patent/WO2006012966A1/en active Application Filing
- 2005-07-06 US US11/659,379 patent/US20080292708A1/en not_active Abandoned
- 2005-07-06 ES ES05763405T patent/ES2387200T3/es active Active
- 2005-07-06 MX MX2007001560A patent/MX2007001560A/es active IP Right Grant
- 2005-07-06 AU AU2005268981A patent/AU2005268981B2/en not_active Ceased
-
2013
- 2013-11-20 US US14/085,334 patent/US20140080911A1/en not_active Abandoned
-
2017
- 2017-01-25 US US15/414,829 patent/US10328034B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2387200T3 (es) | 2012-09-17 |
| EP1784169B1 (en) | 2012-03-21 |
| US20080292708A1 (en) | 2008-11-27 |
| CA2576087A1 (en) | 2006-02-09 |
| AU2005268981A2 (en) | 2006-02-09 |
| CN101001616A (zh) | 2007-07-18 |
| EP1784169A1 (en) | 2007-05-16 |
| ITMI20041628A1 (it) | 2004-11-06 |
| AU2005268981A1 (en) | 2006-02-09 |
| US10328034B2 (en) | 2019-06-25 |
| JP2008509096A (ja) | 2008-03-27 |
| US20140080911A1 (en) | 2014-03-20 |
| PT1784169E (pt) | 2012-06-26 |
| RU2401126C2 (ru) | 2010-10-10 |
| WO2006012966A1 (en) | 2006-02-09 |
| RU2007104354A (ru) | 2008-08-10 |
| MX2007001560A (es) | 2008-03-05 |
| CN101001616B (zh) | 2010-06-16 |
| ATE550040T1 (de) | 2012-04-15 |
| AU2005268981B2 (en) | 2010-05-13 |
| US20170128383A1 (en) | 2017-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1784169T3 (pl) | Polimerowa matryca adhezyjna z grupami karboksylowymi przekształconymi w sole do przezskórnego stosowania | |
| NO20082988L (no) | Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer | |
| AR072492A1 (es) | Dispositivo y administracion transdermica de estrogeno | |
| HK1069534A1 (pl) | ||
| HRP20191795T1 (hr) | Medicinska upotreba spojeva artemizinina i agonista gefirina | |
| ES2194732T3 (es) | Composiciones farmaceuticas orales de liberacion controlada de mesalazina. | |
| WO2008090555A3 (en) | Medical devices having a matrix adhered thereof | |
| ATE506054T1 (de) | Feste formulierungen von ospemifen | |
| CY1112582T1 (el) | Διαδερμικη χορηγηση φεντανυλης | |
| CY2013023I1 (el) | Φαρμακο για την υπερδραστηρια ουροδοχο κυστη περιλαμβανον παραγωγο ανιλιδιου οξικου οξεος ως το ενεργο συστατικο | |
| DK2029121T3 (da) | Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel | |
| RS52169B (en) | STABLE LAKVINIMOD PREPARATIONS | |
| ATE517615T1 (de) | Schmerzstillendes und entzündungshemmendes pflaster zur lokalen anwendung | |
| MX2007002898A (es) | Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo. | |
| WO2007005941A3 (en) | Liver targeted conjugates | |
| MX2012014060A (es) | Sistema de suministro de ingredientes activos. | |
| PE20151147A1 (es) | Sistema de liberacion transdermica | |
| MA34484B1 (fr) | Formulations a base de nalbuphine et leurs utilisations | |
| CO6382109A2 (es) | Formulación de depósito de octreotida con niveles de exposición constantemente altos | |
| DK1820506T3 (da) | Dipyridamol-formuleringer med forlænget frigivelse og fremgangsmåde til fremstilling heraf | |
| IT1257793B (it) | Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato | |
| NO20073457L (no) | Stabile sammensetninger av fenofibrat med fettsyreestere | |
| ATE503458T1 (de) | Reverse mizellen auf basis von phytosterolen und acylglycerolen und therapeutischen verwendungen derselben | |
| ATE347358T1 (de) | Schwimmende orale formulierungen mit kontrollierter freisetzung von betain | |
| DK1143938T3 (da) | Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type |